Early participant reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II

- Sestak, I., Smith, S. G., Howell, A., Forbes, J. F., Cuzick, J.

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial

- Sestak, I., Kealy, R., Nikoloff, M., Fontecha, M., Forbes, J. F., Howell, A., Cuzick, J.